Product Type Insights
DNA chips accounted for the largest share of revenue owing to the presence of a considerable number of
applications. Cancer treatment/diagnostics has been observed to have major share for the usage of biochips.
Other segments contributing for the applications of biochips include genotyping, agricultural biotechnology,
genomic studies, single nucleotide polymorphism and gene expression.
Biochip technology has the ability for miniaturizing chemical & biological assays and molecular biology which
provides a ground for in-depth R&D of molecular biology at a minute level. Furthermore, the ability of
miniaturization is expected to improve even more and enhance the efficiency in terms of inputs and cost
requirements.
End-use Insights
Lab-on-a-chip, cell and tissue array, protein chips and DNA chips find applications in biotechnology &
pharmaceutical companies, research & academic institutes, hospitals & diagnostics and point of care settings
which involves end users. Protein biochips and LOACs have found widespread use for single nucleotide
polymorphism genotyping, gene expression, in vitro diagnosis, expression profiling, drug discovery, high
throughput screening and tissue arrays. The commercialization of the products in the development pipelines of
key market participants is also key towards the potential to drive the growth for the market.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/biochip-market-size
Sophisticated robotic tools are needed for scanning and handling samples which are in micro-scale.
Furthermore, for efficient data analysis efficient bioinformatics system is required. Therefore, this will increase
the need for specific techniques and system which is expected to increase the demand for biochips used in
sophisticated machines. This will consequently increase the price of the biochips and widen the offered product
range in the market.
Regional Insights
North-America accounted for the largest revenue share owing to the presence of government policies
motivating personalized care for the patients and availability of proteomics and genetic profiling infrastructure
across the country, especially in the U.S. There has also been a rise in the usage of NGS (Next Generation
Sequencing) for molecular treatment and clinical diagnosis coupled with microfluidic techniques that add to the
large market share.